Skip to main content
Figure 1 | Critical Care

Figure 1

From: Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery

Figure 1

Confounder-adjusted survival curves of all-cause and cardiovascular mortality according to tertiles of butyrylcholinesterase. Adjusted survival curves demonstrated a significant decrease of 30-day (A, P = 0.017) and long-term (B, P = 0.019) all-cause mortality, as well as a significant decrease of 30-day (C, P = 0.008) and long-term (D, P = 0.007) cardiovascular mortality with increasing serum levels of butyrylcholinesterase.

Back to article page

Critical Care

ISSN: 1364-8535